TABLE 3.
Response by Therapy
| Therapy | No. of Patients | No. of CRs (%) | 
|---|---|---|
| VAD/hyper-CVAD | 61 | 17 (28) | 
| Cytarabine combinations | 54 | 17 (32) | 
| Allogeneic bone marrow transplantation | 22 | 9 (41) | 
| Methotrexate-asparaginase combinations | 52 | 3 (6) | 
| Other combinations | 29 | 4 (14) | 
| Single agent | 70 | 3 (4) | 
CRs indicates complete responses; VAD, vincristine, doxorubicin, and dexamethasone; hyper-CVAD, hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone.